Govt Job: For Science professionals at IIIM | Pay Rs. 60,000 pm
Apply online: CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, one of the constituent units of the Council of Scientific & Industrial Research (CSIR). CSIR is a premier multi-disciplinary R&D organization in India…
India to become hub for Covid-19 antiviral generic drugs: Fitch
India will become the largest global hub for Covid-19 antiviral general drug production after the drug controller granted emergency-use authorisation to several pharmaceutical companies in the country to manufacture and…
Anti-Viral Drug Molnupiravir Has No Observed Safety Concerns: MSD India
Mumbai : Amid safety concerns around Merck’s anti-viral drug Molnupiravir, the American pharma giant came out in defense of its drug developed in collaboration with Ridgeback Biotherapeutics. In a statement,…
Govt Job: For B.Pharm or M.Pharm at NIPER – Pay upto Rs 47,000 PM
Apply online: National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an autonomous institute of National importance and the first national pharma institute in NE India set up by the…
DTAB Agrees To Amend Rules To Display License Holder’s Picture In Retail Pharmacy Shops
New Delhi : The Drugs Technical Advisory Board (DTAB) has approved a proposal to amend the Drugs Rules to have a provision for display of the picture of the license…
Govt Job: For B.Pharm under Ministry of Health and Family Welfare – Annual CTC Rs. 8.3 lakhs
HLL Lifecare Limited (HLL) is a Govt. of India healthcare products manufacturing and services company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare, HLL is…
Pfizer may offer Covid antiviral drug to India at lower price for now
Pfizer may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may…
DTAB Agrees To Amend Rules For Manufacturing Of Unapproved New Drugs Still Under Development
New Delhi : The Centre is expected to amend the New Drugs and Clinical Trial (ND&CT) Rules, 2019 to enable manufacturing of unapproved new drugs while it is still under…
Govt Job: at National Institute for Research – pay upto Rs 59,000 PM
Download the application form: The National Institute for Research in Tuberculosis [Formerly Tuberculosis Research Centre (TRC)], a permanent Institute under the Indian Council of Medical Research (ICMR), is an internationally recognized…
Indian Pharma Sector Expected To Grow 9-11% In FY22: ICRA
New Delhi : India’s pharma sector is expected to grow at 9-11% in FY22, rating agency ICRA said on Tuesday. It attributed the growth to the improving demand for non-Covid…
